Use of therapeutic drug monitoring to treat Elizabethkingia meningoseptica meningitis and bacteraemia in an adult

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 6, 2012, Pages 1558-1560

  Neuner, Elizabeth A ^a   Ahrens, Christine L ^a   Groszek, Joseph J ^a   Isada, Carlos ^a   Vogelbaum, Michael A ^a   Fissell, William H ^a   Bhimraj, Adarsh ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Central nervous system; Cerebral spinal fluid penetration; Pharmacokinetics

Indexed keywords

CIPROFLOXACIN; DEXAMETHASONE; LEVOFLOXACIN; MEROPENEM; NORADRENALIN; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; VANCOMYCIN;

AGED; ANTIBIOTIC THERAPY; BACTEREMIA; BLOOD CULTURE; BRAIN EDEMA; CASE REPORT; COGNITION; CRANIOTOMY; DRUG BLOOD LEVEL; DRUG MONITORING; ELIZABETHKINGIA MENINGOSEPTICA; FEVER; FRONTAL LOBE; GRAM NEGATIVE BACTERIUM; GRAM STAINING; HUMAN; LETHARGY; LETTER; LUMBAR PUNCTURE; MENINGITIS; NASOPHARYNX CARCINOMA; NECK PAIN; SEPTIC SHOCK; TREATMENT OUTCOME;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; CEREBROSPINAL FLUID; DRUG MONITORING; FLAVOBACTERIACEAE; FLAVOBACTERIACEAE INFECTIONS; HUMANS; MENINGITIS, BACTERIAL; SERUM;

EID: 84861142914     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks053     Document Type: Letter

References (9)

1. Chan KH, Chau PY, Wang RY et al. Meningitis caused by Flavobacterium meningosepticum after transsphenoidal hypophysectomy with recovery. Surg Neurol 1983; 20: 294-6.
2. Harrington SP, Perlino CA. Flavobacterium meningosepticum sepsis: disease due to bacteria with unusual antibiotic susceptibility. South Med J 1981; 74: 764-6.
3. Connor MJ Jr, Salem C, Bauer SR et al. Therapeutic drug monitoring of piperacillin-tazobactam using spent dialysate effluent in patients receiving continuous venovenous hemodialysis. Antimicrob Agents Chemother 2011; 55: 557-60.
4. Nau R, Kinzig-Schippers M, Sorgel F et al. Kinetics of piperacillin and tazobactam in ventricular cerebrospinal fluid of hydrocephalic patients. Antimicrob Agents Chemother 1997; 41: 987-91.
5. Ozkalay N, Anil M, Agus N et al. Community-acquired meningitis and sepsis caused by Chryseobacterium meningosepticum in a patient diagnosed with thalassemia major. J Clin Microbiol 2006; 44: 3037-9.
6. Kirby JT, Sader HS, Walsh TR et al. Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp.: report from the SENTRY Antimicrobial Surveillance Program (1997-2001). J Clin Microbiol 2004; 42: 445-8.
7. Tunkel AR, Hartman BJ, Kaplan SL et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004; 39: 1267-84.
8. Maeda T, Takahashi K, Ohtsu N et al. Identification of influx transporter for the quinolone antibacterial agent levofloxacin. Mol Pharm 2007; 4: 85-94.
9. de Lange EC. Potential role of ABC transporters as a detoxification system at the blood-CSF barrier. Adv Drug Deliv Rev 2004; 56: 1793-809.